Diabete Type 2 Clinical Trial
Official title:
Study of Using Serum Fetuin-A as a Marker in Obesity and Type 2 Diabetes Mellitus
The aim of this study is to assess the significance of serum fetuin-A as a marker of obesity and type 2 diabetes mellitus. We used multiple statistical approaches to determine that the fetuin-A level is correlated to body mass index (BMI) as well as random blood sugar in type 2 diabetic patients. Also, we found that there is a Positive correlation between the serum fetuin-A levels and the level of glycosylated hemoglobin (HbA1c) in diabetic patients.
The study was a case-control study. We started the study to be performed on eighty subjects
divided into four groups:
The first group: include twenty subjects with type 2 diabetes mellitus The second group:
include twenty obese subjects whose body mass index is 30 or over The third group: include
twenty obese subjects with type 2 diabetes mellitus The fourth group includes twenty
apparently healthy subjects as control.
In this study, we concluded that:
1. Serum fetuin-A can be used as a biomarker and independent risk factor and marker for
diagnosis of DM and DM has a detrimental effect on serum fetuin-A fetuin-A could be of
relevance for the development of insulin resistance
2. Higher fetuin-A concentrations were associated with type 2 diabetes and insulin
resistance
3. Increased serum fetuin-A levels constitute an independent marker of lipid profile.
4. fetuin-A may play a role in the pathogenesis of T2DM.
5. The inhibition of insulin receptor by fetuin-A may lead to increased lipolysis and
efflux of free fatty acids from adipose tissue. This could explain associated
dyslipidemia observed in type 2 diabetic patients in the present study.
Finally, our finding that high plasma fetuin-A levels predict the incidence of type 2
diabetes independently of other established risk factors supports the hypothesis that
fetuin-A may play a role in the development of type 2 diabetes.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04940962 -
Translational Study Using Human Abdominal Adipose Tissue Biopsies to Investigate the Role of Cannabinoid Receptor 1 (CB1) in Controlling Endocannabinoid and Adipokine Secretion
|
N/A | |
| Completed |
NCT05359341 -
Which is Better to Start With DPP-4 Inhibitors or SGLT-2 Inhibitors in Egyptian Diabetic Patients?
|
N/A | |
| Recruiting |
NCT04700813 -
Research Study for Rare Pathogenic Mutations Causing Type 2 Diabetes and Complications
|
||
| Completed |
NCT05413330 -
Corticosteroid Injection Combined With Cataract Surgery in Diabetic Eyes.
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04927377 -
Accessible and Inclusive Diabetes Telecoaching Self-Management Program
|
N/A | |
| Completed |
NCT05585268 -
Electronic Decision Support for Deprescribing in Patients on Hemodialysis
|
N/A | |
| Active, not recruiting |
NCT05088616 -
Native American Diabetes Project
|
N/A | |
| Not yet recruiting |
NCT03273738 -
Vascular and Metabolic Changes in Postmenopausal Diabetics
|
||
| Active, not recruiting |
NCT04642911 -
Longterm Follow-up of Subjects With Diabetes 2 Type Treatment With ex Vivo Gene Therapy
|
||
| Withdrawn |
NCT04283617 -
Reversibility of Brain Glucose Transport and Metabolism in T2DM: an Intervention Study
|
N/A | |
| Recruiting |
NCT04769687 -
Symbiotics and Systemic Inflammation in Chronic Kidney Disease
|
Phase 2 | |
| Withdrawn |
NCT06104358 -
Ph 2a Study of HU6 on Energy Metabolism, Muscle and Liver Substrate Metabolism, and Mitochondrial Function in Subjects Who Are Overweight or Obese With Type 2 Diabetes
|
Phase 2 | |
| Recruiting |
NCT03341793 -
Impact of Changes in Muscle Secretome in the Remission of Type 2 Diabetes Mellitus Induced by Bariatric Surgery
|
N/A | |
| Not yet recruiting |
NCT06080802 -
The Effect of Addition of Metformin to SGLT2 In Diabetic Patients With Heart Failure With Preserved Ejection Fraction
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04485845 -
Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression
|
Phase 4 | |
| Recruiting |
NCT05050500 -
The Effect of Dapagliflozin on the Short-term Prognosis of Patients With Acute Myocardial Infarction
|
Phase 4 | |
| Completed |
NCT04115657 -
The Effect of Different Starches of Boba Pearls and Sugar Substitutes Used in Milk Tea on Glycaemia, Insulinaemia and Appetite Control (Pearl Study)
|
N/A | |
| Completed |
NCT06188572 -
The Effect of Peripheral Neuropathy Symptoms on Temporomandibular Joint Functionality
|
||
| Completed |
NCT04120844 -
Effectiveness of Motivational Interviewing on Improving Care for Type 2 Diabetes Mellitus Patients in China
|
N/A | |
| Completed |
NCT05789706 -
Use of a Smart-phone Based Medication Adherence Platform to Improve Outcomes in Uncontrolled Non-insulin Dependent Diabetes Among Veterans
|
N/A |